
### [MONDO:0002659](http://purl.obolibrary.org/obo/MONDO_0002659)
**Label:** uveal cancer

**Subclasses:** [MONDO:0007966](http://purl.obolibrary.org/obo/MONDO_0007966) (melanoma, uveal), [MONDO:0011695](http://purl.obolibrary.org/obo/MONDO_0011695) (melanoma, uveal, susceptibility to, 1), [MONDO:0006486](http://purl.obolibrary.org/obo/MONDO_0006486) (uveal melanoma), [MONDO:0011696](http://purl.obolibrary.org/obo/MONDO_0011696) (melanoma, uveal, susceptibility to, 2), 

**Corr. equiv. classes:** [OMIM:606661](http://purl.obolibrary.org/obo/OMIM_606661), [OMIM:606660](http://purl.obolibrary.org/obo/OMIM_606660), [Orphanet:39044](http://www.orpha.net/ORDO/Orphanet_39044), [OMIM:155720](http://purl.obolibrary.org/obo/OMIM_155720), 

**Class expressions from DL-Learner:**

- [HP:0012055](http://purl.obolibrary.org/obo/HP_0012055) (Ciliary body melanoma) 62.50%
- [HP:0012054](http://purl.obolibrary.org/obo/HP_0012054) (Choroidal melanoma) 62.50%
- [HP:0011524](http://purl.obolibrary.org/obo/HP_0011524) (Iris melanoma) 62.50%
- [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) and [HP:0200026](http://purl.obolibrary.org/obo/HP_0200026) (Ocular pain) 62.50%
- [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) and [HP:0100533](http://purl.obolibrary.org/obo/HP_0100533) (Inflammatory abnormality of the eye) 62.50%
- [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) and [HP:0100012](http://purl.obolibrary.org/obo/HP_0100012) (Neoplasm of the eye) 62.50%
- [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) and [HP:0030800](http://purl.obolibrary.org/obo/HP_0030800) (Abnormal visual accommodation) 62.50%
- [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) and [HP:0030786](http://purl.obolibrary.org/obo/HP_0030786) (Photopsia) 62.50%
- [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 62.50%
- [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) 62.50%
- [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) 62.50%
- [HP:0012632](http://purl.obolibrary.org/obo/HP_0012632) (Abnormal intraocular pressure) and [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) 62.50%
- [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) 62.50%
- [HP:0012508](http://purl.obolibrary.org/obo/HP_0012508) (Metamorphopsia) and [HP:0012776](http://purl.obolibrary.org/obo/HP_0012776) (Abnormality of the ciliary body) 62.50%
- [HP:0012055](http://purl.obolibrary.org/obo/HP_0012055) (Ciliary body melanoma) and [HP:0200026](http://purl.obolibrary.org/obo/HP_0200026) (Ocular pain) 62.50%


